|VACCINATION SCHEDULE: HIV-INFECTED ADULTS|
*Adapted from the Advisory Committee on Immu–
|For all persons in this category
who meet the age requirements
and who lack evidence of im–
munity (eg, lack of documentation
of vaccination or have no
evidence of prior infection)
|Recommended if some other
risk factor is present (eg, on the
basis of medical, occupational,
lifestyle, or other indications)
|Vaccine||CD4 T-lymphocyte count|
|<200 cells/µL||≥200 cells/µL|
|Influenza (inactivated)†||1 dose IIV annually|
|Pneumococcal polysaccharide (PPSV23)||1 dose; one time revaccination recommended
after 5yr (or at age >65yrs)
|Pneumococcal 13‑valent conjugate (PCV13)||1 dose*|
|Hepatitis B†||3 doses|
|Tetanus, diphtheria, pertussis (Td/Tdap)†||Substitute one-time dose of Tdap for Td booster;
then boost with Td every 10yrs
|Human papillomavirus (HPV)†||3 doses for males and females through age 26yrs|
|Measles, mumps, rubella (MMR)†||Contraindicated||1 or 2 doses|
|Hepatitis A†||2 doses|
|Meningococcal†||1 or more doses|
*Pneumococcal vaccine-naive: 1 dose of PCV13, then 1 dose of PPSV23 8wks later. Previously received ≥1 doses of PPSV23: give PCV13 dose ≥1yr after the last PPSV23 dose was received. Additional PPSV23 doses required: give 1st dose ≥8wks after PCV13 and ≥5yrs after most recent PPSV23 dose.
†Covered by the Vaccine Injury Compensation Program.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. 2013 May.
Please login or register first to view this content.